Sustained-release formulations of topiramate

Details for Australian Patent Application No. 2007319141 (hide)

Owner Supernus Pharmaceuticals Inc.

Inventors Vieira, Michael L.; Bhatt, Padmanabh P.; Wang, Hua; Liang, Likan

Agent Spruson & Ferguson

Pub. Number AU-A-2007319141

PCT Pub. Number WO2008/061226

Priority 60/859,502 17.11.06 US

Filing date 16 November 2007

Wipo publication date 22 May 2008

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/061226 Priority application(s): WO2008/061226

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007319146-Purification of molybdenum technical oxide

2007319122-Improvements in or relating to retinal scanning